Releases and presentations

Releases and presentations

Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.

Contact information for the media: info@bbs-artebone.fi from which you can also request additional media material

Archived releases can be found:
2018
2019
2020
2021

18.11.2022 BBS-Bioactive Bone Substitutes Oyj: The subscription period for the first warrant series starts on 21 November 2022 – the subscription price is EUR 0.92 per share
18.11.2022 BBS-Bioactive Bone Substitutes – Inside information: The first audit completed by the Notified Body, CE marking process may continue as planned
04.11.2022 BBS-Bioactive Bone Substitutes announces plans to withdraw its dual listing on Nasdaq First North Growth Market Sweden
04.11.2022 BBS-Bioactive Bone Substitutes has resolved on a share issue without consideration to the company itself
07.10.2022 Jari Kortesluoma appointed as CFO and member of the management team of BBS-Bioactive Bone Substitutes Plc
31.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Pekka Jalovaara
31.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Ahti Paananen
31.08.2022 BBS-Bioactive Bone Substitutes Plc: Change in BBS-Bioactive Bonesubstitutes Plc’s management
25.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Oili Halonen
25.08.2022 BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions – Pekka Jalovaara

24.02.2022 Financial Statements Review 1.1.-31.12.2021 (unaudited)
23.02.2022 Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position
11.01.2022 US Patent for the Manufacture of ARTEBONE® product